CashuuniQure N.V. Faces Class Action Lawsuits Over Alleged Investor Misleading Communications2 days ago
CashuuniQure N.V. Faces Class Action Lawsuit Over Huntington's Disease Drug Misrepresentations4 days ago
prnewswire.comQURE SHAREHOLDER NOTICE: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of "Distorted" Data1 day ago
prnewswire.comQURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm2 days ago
prnewswire.comuniQure N.V. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - QURE2 days ago
prnewswire.comLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 13, 2026 in uniQure Lawsuit - QURE4 days ago
prnewswire.comQURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit6 days ago
prnewswire.comuniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC8 days ago
prnewswire.comuniQure N.V. (QURE) Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP: Investors Face April 13, 2026, Deadline9 days ago
prnewswire.comuniQure N.V. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 13, 2026 to Discuss Your Rights - QURE12 days ago
benzinga.comuniQure Shares Surge 26% On US FDA Shakeup Even As Momentum Tumbles: Will New Leadership Greenlight Huntington's Therapy?12 days ago